Page - (000265) - in Biomedical Chemistry: Current Trends and Developments

Huang, P.; Chubb, S.; Hertel, L. W.; Grindey, G. B.; Plunkett, W. (1991). Action of 2’,2’- difluorodeoxycytidine on DNA synthesis. Cancer Research, 51, 6110-6117. Hummel, G.; Reineke, U.; Reimer, U. (2006). Translating peptides into small molecules. Molecular BioSystems, 2, 499-508. Hutunen, K. M.; Raunio, H.; Rautio, J. (2011). Prodrugs-from serendipity to rational design. Pharmacological Reviews, 63, 750-771. Ischakov, R.; Adler-Abramovich, L.; Buzhansky, L.; Shekhter, T.; Gazit, E. (2013). Peptide-based hydrogel nanoparticles as effective drug delivery agents. Bioorganic and Medicinal Chemistry, 21, 3517-3522. Jeu, L.; Fung, H. B. (2004). Daptomycin: a cyclic lipopeptide antimicrobial agent. Clinical Therapeutics, 1728-1757. Johnstone, B.; Alini, M.; Cucchiarini, M.; Dodge, G. R.; Eglin, D.; Guilak, F.; Madry, H.; Mata, A.; Mauck, R. L.; Semino, C. E. (2013). Tissue engineering for articular cartilage repair-the state of the art,. European Cells and Materials, 25, 248-267. Jung, D.; Dorr, A. (1999). Single-dose pharmacokinetics of valganciclovir in HIV- and CMVseropositive subjects. Journal of Clinical Pharmacology 39, 800-804. Kageyama, T.; Nakamura, M.; Matsuo, A.; Yamasaki, Y.; Takakura, Y.; Hashida, M.; Kanai, Y.; Naito, M.; Tsuruo, T.; Minato, N.; Shimohama, S. (2000). The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Research, 879, 115-121. Kan, E. J.; Demel, R. A.; Breukink, E.; van der Bent., A.; de Kruijff, B. (2002). Clananin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry, 18, 7529-7539. Kanai, Y.; Segawa, H.; Miyamoto, K., Uchino, H.; Takeda, E.; Endou, H. (1998). Expression cloning and characterization of a transporter for large neutral amino 367 acids activated by the heavy chain of 4F2 antigen (CD98). Journal of Biological Chemistry, 273, 23629-23632. Kaspar, A. A.; Reichert, J. M. (2013). Future directions for peptide therapeutics developments. Drug Discovery Today, 18, 807-817. Killian, D. M.; Hermeling, S.; Chikhale, P. J. (2007). Targeting the cerebrovascular large neutral amino acid transporter (LAT1) isoform using a novel disulfide-based brain drug delivery system. Drug Delivery, 14, 25-31. Kim, I.; Chu, X. Y.; Kim, S.; Provoda, C. J.; Lee, K. D.; Amidon, G. L. (2003). Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase. Journal of Biology Chemistry, 278, 25348-25356. Kim, I.; Song, X.; Vig, B. S.; Mittal, S.; Shin, H. C.; Lorenzi, P. J.; Amidon, G. L. (2004). A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein. Molecular Pharmaceutics, 1, 117-127. Kirk, K. (2001). Membrane transport in the malaria-infected erythrocyte. Physiological Reviews, 81, 495-537. Kotthaus, J.; Hungeling, H.; Reeh, C.; Kotthaus, J.; Schade, D.; Wein, S.; Wolffram, S.; Clement, B. (2011). Synthesis and biological evaluation of L-valine-amidoximeesters as double prodrugs of amidines. Bioorganic and Medicinal Chemistry, 19, 1907-1914. Kragol, G.; Lovas, S.; Varadi, G.; Condie, B. A.; Hoffmann, R.; Otvos, L. Jr. (2001). The antibacterial peptide pyrrhocoricin inhibits the atpase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry, 40, 3016-3026.